Amputations are associated with markedly reduced long-term survival in patients with diabetic foot disease. However, there is paucity of long-term survival data in published literature.
We searched the electronic case records and laboratory details of patients who underwent amputations between 1997 and 2006 to obtain at least 10 years of follow up data after the surgery to assess the survival rates and possible risk factors reducing survival in the year 2016. Amputation level below ankle was considered as minor and above ankle as major amputations.
Of the 233 cases (159 males; median age 68 years), 161 had major amputations. Of the 72 cases who had minor amputations initially, 63 needed a further amputation or contralateral amputation on follow up. One hundred seventy-seven patients (76%) were not alive after 10 years of follow up. The survival rates at 1, 3, 5, 7, and ≥10 years were 64%, 50%, 40%, 34%, and 24%, respectively. Maximum number of deaths occurred within 4 months of amputations. There was no difference between survival rates following major or minor amputations and among males or females. The only statistically significant parameter affecting lower survival rate was age ≥70 years, with each additional year of age increasing the hazard by a factor of 1.039 (95% CI: 1.024–1.054) or 3.9% (2.4–5.4%).
Five-year and 10-year survival rates were 40% and 24%, respectively, following diabetic foot amputations. Higher age ≥70 years was associated with lower survival rate compared with younger age groups after lower extremity amputations.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
S.C. Mishra, K.C. Chhatbar, A. Kashikar, A. Mehndiratta, Diabetic foot. BMJ 359, j5064 (2017). https://doi.org/10.1136/bmj.j5064
D.G. Armstrong, A.J.M. Boulton, S.A. Bus, Diabetic foot ulcers and their recurrence. N. Engl. J. Med. 376(24), 2367–2375 (2017). https://doi.org/10.1056/NEJMra1615439
M.B. Brennan, T.M. Hess, B. Bartle, J.M. Cooper, J. Kang, E.S. Huang, M. Smith, M.W. Sohn, C. Crnich, Diabetic foot ulcer severity predicts mortality among veterans with type 2 diabetes. J. Diabetes Complications 31(3), 556–561 (2017). https://doi.org/10.1016/j.jdiacomp.2016.11.020
N. Tentolouris, S. Al‐Sabbagh, M.G. Walker, A.J. Boulton, E.B. Jude, Mortality in diabetic and nondiabetic patients after amputations performed from 1990 to 1995: a 5‐year follow‐up study. Diabetes Care 27(7), 1598–1604 (2004). https://doi.org/10.2337/diacare.27.7.1598
P.W. Moxey, P. Gogalniceanu, R.J. Hinchliffe, I.M. Loftus, K.J. Jones, M.M. Thompson, P.J. Holt, Lower extremity amputations—a review of global variability in incidence. Diabet. Med. 28(10), 1144–1153 (2011). https://doi.org/10.1111/j.1464-5491.2011.03279.x
D.J. Margolis, W. Jeffcoate, Epidemiology of foot ulceration and amputation: can global variation be explained? Med. Clin. North Am. 97(5), 791–805 (2013). https://doi.org/10.1016/j.mcna.2013.03.008
A.J. Boulton, The pathway to foot ulceration in diabetes. Med. Clin. North Am. 97(5), 775–790 (2013). https://doi.org/10.1016/j.mcna.2013.03.007
M. Kerr, G. Rayman, W.J. Jeffcoate, Cost of diabetic foot disease to the National Health Service in England. Diabet. Med. 31(12), 1498–1504 (2014). https://doi.org/10.1111/dme.12545
C.A. Behrendt, B. Sigvant, Z. Szeberin, B. Beiles, N. Eldrup, I.A. Thomson, M. Venermo, M. Altreuther, G. Menyhei, J. Nordanstig, M. Clarke, H.C. Rieß, M. Björck, E.S. Debus, International variations in amputation practice: a VASCUNET report. Eur. J. Vasc. Endovasc. Surg. 56(3), 391–399 (2018). https://doi.org/10.1016/j.ejvs.2018.04.017
L.N. McEwen, K.R. Ylitalo, M. Munson, W.H. Herman, J.S. Wrobel, Foot complications and mortality: results from translating research into action for diabetes (TRIAD). J. Am. Podiatr. Med. Assoc. 106(1), 7–14 (2016). https://doi.org/10.7547/14-115
American Cancer Society. Cancer Facts & Figures 2013. (American Cancer Society, Atlanta, 2013), https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/cancer-facts-figures-2013.html. Accessed 27 Oct 2019
American Cancer Socitey. Colorectal Cancer Facts & Figures 2014–2016. (American Cancer Society, Atlanta, 2014). Accessed 27 Oct 2019
M.E. López-Valverde, J. Aragón-Sánchez, A. López-de-Andrés, V. Guerrero-Cedeño, R. Tejedor-Méndez, G. Víquez-Molina, R. Jiménez-García, Perioperative and long-term all-cause mortality in patients with diabetes who underwent a lower extremity amputation. Diabetes Res. Clin. Pr. 141, 175–180 (2018). https://doi.org/10.1016/j.diabres.2018.05.004
D.C. Jupiter, J.C. Thorud, C.J. Buckley, N. Shibuya, The impact of foot ulceration and amputation on mortality in diabetic patients. I: from ulceration to death, a systematic review. Int. Wound J. 13(5), 892–903 (2016). https://doi.org/10.1111/iwj.12404
A. López-de-Andrés, R. Jiménez-García, M.D. Esteban-Vasallo, V. Hernández-Barrera, J. Aragon-Sánchez, I. Jiménez-Trujillo, J. de Miguel-Diez, M.A. Palomar-Gallego, M. Romero-Maroto, N. Perez-Farinos, Time trends in the incidence of long-term mortality in T2DM patients who have undergone a lower extremity amputation. Results of a descriptive and retrospective cohort study. J. Clin. Med. 8(10), pii: E1597 (2019). https://doi.org/10.3390/jcm8101597
Ü. Gök, Ö. Selek, A. Selek, A. Güdük, M.Ç. Güner, Survival evaluation of the patients with diabetic major lower-extremity amputations. Musculoskelet. Surg. 100(2), 145–148 (2016). https://doi.org/10.1007/s12306-016-0399-y
Y.Y. Huang, C.W. Lin, H.M. Yang, S.Y. Hung, I.W. Chen, Survival and associated risk factors in patients with diabetes and amputations caused by infectious foot gangrene. J. Foot Ankle Res. 11, 1 (2018). https://doi.org/10.1186/s13047-017-0243-0
T.E. Wilbek, R.B. Jansen, B. Jørgensen, O.L. Svendsen, Risk factors for premature death in diabetes patients who undergo amputations below ankle level. Exp. Clin. Endocrinol. Diabetes 126(1), 61–65 (2018). https://doi.org/10.1055/s-0043-109700
P.J. Kelly, P.M. Clarke, A.J. Hayes, U.G. Gerdtham, J. Cederholm, P. Nilsson, B. Eliasson, S. Gudbjornsdottir, Predicting mortality in people with type 2 diabetes mellitus after major complications: a study using Swedish National Diabetes Register data. Diabet. Med. 31(8), 954–962 (2014). https://doi.org/10.1111/dme.12468
I. Desormais, V. Aboyans, A. Bura, J. Constans, J.P. Cambou, E. Messas, A. Labrunie, P. Lacroix, Anemia, an independent predictive factor for amputation and mortality in patients hospitalized for peripheral artery disease. Eur. J. Vasc. Endovasc. Surg. 48(2), 202–207 (2014). https://doi.org/10.1016/j.ejvs.2014.04.005
Conflict of interest
The authors declare that they have no conflict of interest.
This study was performed as a retrospective clinical audit at the Lancashire Teaching Hospitals NHS Trust and the Institutional Review Board had approved this audit at the time of initiation of the study and agreed for publication of the results in biomedical periodicals.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Soo, B.P., Rajbhandari, S., Egun, A. et al. Survival at 10 years following lower extremity amputations in patients with diabetic foot disease. Endocrine 69, 100–106 (2020). https://doi.org/10.1007/s12020-020-02292-7
- Diabetic foot ulcer
- Lower extremity amputations
- Survival rate